Has Biana Trost, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,153 in general payments to Biana Trost, MD across 19 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Biana Trost, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Biana Trost, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Biana Trost, MD

Cardiovascular Disease · New York, NYNPI 1063731602

Payments from drug & device makers

$1,153in general payments, 2019–2025

Across 19 payments — averaging $60.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$738
E.r. Squibb & Sons, L.L.C.$120
Boston Scientific$74
Kiniksa Pharmaceuticals International, PLC$65
Atricure, Inc.$58
Lantheus Medical Imaging, Inc.$54
plus $44 from 1 others

What the payments were for

Food & beverage$1,153100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	8	$738
E.r. Squibb & Sons, L.L.C.	4	$120
Boston Scientific	1	$74
Kiniksa Pharmaceuticals International, PLC	2	$65
Atricure, Inc.	1	$58
Lantheus Medical Imaging, Inc.	2	$54
Cardiva Medical, Inc.	1	$44

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Mitra Clip system$473
Ultreon$110

How this compares

$1,153 in reported general payments places this provider in the 40th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Medicare billing

Part B allowed, 2024

$65,841

Medicare patients

661

Services billed

1,017

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	56	$59,717
JardianceEmpagliflozin	13	$16,104
EntrestoSacubitril/Valsartan	19	$15,934
Metoprolol Succinate	92	$1,368
Atorvastatin Calcium	73	$652
Valsartan	12	$409
Rosuvastatin Calcium	38	$376
Amlodipine Besylate	49	$304
Losartan Potassium	49	$295
Ezetimibe	11	$272
ClopidogrelClopidogrel Bisulfate	37	$179
Nifedipine ErNifedipine	14	$136
Furosemide	35	$93
Carvedilol	16	$86
Hydrochlorothiazide	22	$85

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in New York

James MinNew York$41.1M
Robert RosensonNew York$6.9M
Roxana MehranNew York$6.4M
Roger HajjarNew York$5.2M
Philippe GenereuxNew York$4.4M
Gregg StoneNew York$3.7M
Valentin FusterNew York$2.9M
Tamim NazifNew York$2.2M
Howard WeintraubNew York$1.7M
Anuradha Lala-TrindadeNew York$1.5M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →